Published online January 3, 2005
PEDIATRICS Vol. 115 No. 1 January 2005, pp. 1-4 (doi:10.1542/peds.2004-1463)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (91)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, H.-C.
Right arrow Articles by Oh, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, H.-C.
Right arrow Articles by Oh, W.
Related Collections
Right arrow Premature & Newborn
Right arrowRelated AAP Red Book topics:
Yersinia enterocolitica and...

Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis in Very Low Birth Weight Infants

Hung-Chih Lin, MD*, Bai-Horng Su, MD, PhD*, An-Chyi Chen, MD*, Tsung-Wen Lin, MD*, Chang-Hai Tsai, MD, PhD*,{ddagger}, Tsu-Fuh Yeh, MD, PhD* and William Oh, MD§

* Department of Pediatrics, China Medical University Hospital, China Medical University, Taichung, Taiwan
{ddagger} Taichung Healthcare and Management University, Taichung, Taiwan
§ Department of Pediatrics, Brown Medical School, Providence, Rhode Island

Objective. We evaluated the efficacy of probiotics in reducing the incidence and severity of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants.

Patients and Methods. A prospective, masked, randomized control trial was conducted to evaluate the beneficial effects of probiotics in reducing the incidence and severity of NEC among VLBW (<1500 g) infants. VLBW infants who started to fed enterally and survived beyond the seventh day after birth were eligible for the trial. They were randomized into 2 groups after parental informed consents were obtained. The infants in the study group were fed with Infloran (Lactobacillus acidophilus and Bifidobacterium infantis) with breast milk twice daily until discharged. Infants in the control group were fed with breast milk alone. The clinicians caring for the infants were blinded to the group assignment. The primary outcome was death or NEC (≥ stage 2).

Results. Three hundred sixty-seven infants were enrolled: 180 in the study group and 187 in the control group. The demographic and clinical variables were similar in both groups. The incidence of death or NEC (≥ stage 2) was significantly lower in the study group (9 of 180 vs 24 of 187). The incidence of NEC (≥ stage 2) was also significantly lower in the study when compared with the control group (2 of 180 vs 10 of 187). There were 6 cases of severe NEC (Bell stage 3) in the control group and none in the study group. None of the positive blood culture grew Lactobacillus or Bifidobacterium species.

Conclusion. Infloran as probiotics fed enterally with breast milk reduces the incidence and severity of NEC in VLBW infants.

Key Words: probiotics • necrotizing enterocolitis • sepsis • mortality • very low birth weight infants

Abbreviations: NEC, necrotizing enterocolitis • VLBW, very low birth weight

Accepted Sep 23, 2004.




This article has been cited by other articles:


Home page
 J. Nutr.Home page
H. N. Lafeber, E. A. M. Westerbeek, A. van den Berg, W. P. F. Fetter, and R. M. van Elburg
Nutritional Factors Influencing Infections in Preterm Infants
J. Nutr., September 1, 2008; 138(9): 1813S - 1817S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. H. Siggers, J. Siggers, M. Boye, T. Thymann, L. Molbak, T. Leser, B. B. Jensen, and P. T. Sangild
Early Administration of Probiotics Alters Bacterial Colonization and Limits Diet-Induced Gut Dysfunction and Severity of Necrotizing Enterocolitis in Preterm Pigs
J. Nutr., August 1, 2008; 138(8): 1437 - 1444.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
T. D. Soltau and R. L. Schelonka
Immune Modification to Prevent Nosocomial Sepsis in Hospitalized Newborns
NeoReviews, May 1, 2008; 9(5): e199 - e205.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
E. C. Eichenwald and A. R. Stark
Management and Outcomes of Very Low Birth Weight
N. Engl. J. Med., April 17, 2008; 358(16): 1700 - 1711.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. H. Siggers, T. Thymann, B. B. Jensen, L. Molbak, P. M. H. Heegaard, M. Schmidt, R. K. Buddington, and P. T. Sangild
Elective cesarean delivery affects gut maturation and delays microbial colonization but does not increase necrotizing enterocolitis in preterm pigs
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R929 - R938.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
F. Guarner
Studies with Inulin-Type Fructans on Intestinal Infections, Permeability, and Inflammation
J. Nutr., November 1, 2007; 137(11): 2568S - 2571S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. Veereman
Pediatric Applications of Inulin and Oligofructose
J. Nutr., November 1, 2007; 137(11): 2585S - 2589S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. Isakow, L. E. Morrow, and M. H. Kollef
Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations
Chest, July 1, 2007; 132(1): 286 - 294.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
K. D. Karpa
Probiotics for Clostridium difficile Diarrhea: Putting It into Perspective
Ann. Pharmacother., July 1, 2007; 41(7): 1284 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 Med Care Res RevHome page
E. Shenkman, C. Knapp, D. Sappington, B. Vogel, and D. Schatz
Persistence of High Health Care Expenditures among Children in Medicaid
Med Care Res Rev, June 1, 2007; 64(3): 304 - 330.
[Abstract] [PDF]

Home page
 Nutr Clin PractHome page
J. M. Saavedra
Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects
Nutr Clin Pract, June 1, 2007; 22(3): 351 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
J. Neu, M. Douglas-Escobar, and M. Lopez
Microbes and the Developing Gastrointestinal Tract
Nutr Clin Pract, April 1, 2007; 22(2): 174 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. Neu
Gastrointestinal development and meeting the nutritional needs of premature infants
Am. J. Clinical Nutrition, February 1, 2007; 85(2): 629S - 634S.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. Pietz, B. Achanti, L. Lilien, E. C. Stepka, and S. K. Mehta
Prevention of Necrotizing Enterocolitis in Preterm Infants: A 20-Year Experience
Pediatrics, January 1, 2007; 119(1): e164 - e170.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
P. T. Sangild
Gut Responses to Enteral Nutrition in Preterm Infants and Animals
Experimental Biology and Medicine, December 1, 2006; 231(11): 1695 - 1711.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
C. Hammerman, A. Bin-Nun, and M. Kaplan
Safety of probiotics: comparison of two popular strains
BMJ, November 11, 2006; 333(7576): 1006 - 1008.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
R J Schanler
Probiotics and necrotising enterocolitis in premature infants.
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2006; 91(6): F395 - F397.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Jilling, D. Simon, J. Lu, F. J. Meng, D. Li, R. Schy, R. B. Thomson, A. Soliman, M. Arditi, and M. S. Caplan
The Roles of Bacteria and TLR4 in Rat and Murine Models of Necrotizing Enterocolitis.
J. Immunol., September 1, 2006; 177(5): 3273 - 3282.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
C. C. Roy, C. L. Kien, L. Bouthillier, and E. Levy
Short-Chain Fatty Acids: Ready for Prime Time?
Nutr Clin Pract, August 1, 2006; 21(4): 351 - 366.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
M. D. Cabana, A. L. Shane, C. Chao, and M. Oliva-Hemker
Probiotics in Primary Care Pediatrics
Clinical Pediatrics, June 1, 2006; 45(5): 405 - 410.
[Abstract] [PDF]

Home page
 NeoReviewsHome page
N. Jesse and J. Neu
Necrotizing Enterocolitis: Relationship to Innate Immunity, Clinical Features, and Strategies for Prevention
NeoReviews, March 1, 2006; 7(3): e143 - e150.
[Full Text] [PDF]

Home page
 PediatricsHome page
D. R. Mack
Probiotics and Necrotizing Enterocolitis
Pediatrics, July 1, 2005; 116(1): 293 - 293.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
Journal Watch
Arch. Dis. Child., May 1, 2005; 90(5): 544 - 545.
[Full Text] [PDF]

Home page
 PediatricsHome page
D. K. Ng, C.-h. Chan, P.-y. Chow, and K.-l. Kwok
Possible Confounding Factors in an Oral Probiotics Trial: Breast Milk
Pediatrics, May 1, 2005; 115(5): 1442 - 1443.
[Full Text] [PDF]

Home page
 JWatch GeneralHome page
Probiotics for Infants: Two Studies, Two Successes
Journal Watch (General), February 11, 2005; 2005(211): 3 - 3.
[Full Text]

Home page
 JWatch PediatricsHome page
Probiotics in Infants: Two Studies, Two Successes
Journal Watch Pediatrics and Adolescent Medicine, February 1, 2005; 2005(201): 2 - 2.
[Full Text]

Home page
 PediatricsHome page
R. M. Kliegman and R. E. Willoughby
Prevention of Necrotizing Enterocolitis With Probiotics
Pediatrics, January 1, 2005; 115(1): 171 - 172.
[Full Text] [PDF]

Home page
 PediatricsHome page
E. F. Bell
Preventing Necrotizing Enterocolitis: What Works and How Safe?
Pediatrics, January 1, 2005; 115(1): 173 - 174.
[Full Text] [PDF]